Ziconotide spinal pump for chemo nerve pain
Treatments studied
Part of Pain clinical trials.
This trial tests a spinal pump delivering ziconotide to treat nerve pain caused by chemotherapy. It may help patients who have tried other pain medicines but still have significant pain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 to 100
- You have nerve pain from chemotherapy
- You are already scheduled to get a spinal pump with ziconotide by Dr. Beuer
- You have no allergy to ziconotide and no expected drug interactions
- If you currently take opioid pain medicine, you must stop for 2 weeks before the pump is placed
- You do not have neuropathy from diabetes or other causes, and you do not have a spinal cord stimulator
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a new type of spinal cord stimulator (SCS) can reduce pain caused by chemotherapy. If you have lasting nerve pain after cancer treatment and standard pain medications haven't helped, this device might offer relief.
This trial tests whether a small implanted device that sends mild electrical signals to your spinal cord can reduce pain caused by chemotherapy drugs. If you have long-lasting nerve pain in your legs from cancer treatment that hasn't improved with medications, this study may help.
This trial tests whether acupuncture and compression therapy can prevent nerve damage caused by taxane chemotherapy in early-stage breast cancer. It aims to reduce numbness, tingling, or pain in the hands and feet.
This trial is testing a wearable device (gloves and boots) that applies gentle compression to your hands and feet during chemotherapy. It aims to prevent or reduce nerve damage (numbness, tingling, pain) that some chemotherapy drugs can cause.
This study looks at a medicine called ziconotide, given through a pump in your spine (intrathecal delivery) to treat chronic pain that is not from cancer. It aims to learn how safe and effective this treatment is in real-world patients.
This study tests a spinal cord stimulator—a device that sends mild electrical pulses to the spine—to see if it can reduce severe nerve pain that lasts more than 6 months after chemotherapy. It is for people who have tried other treatments like duloxetine but still have significant pain.
Hear when a new Chemotherapy Induced Peripheral Neuropathy (CIPN) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.